Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Beacon Pharmaceuticals Revenue

In the fiscal year ending June 30, 2026, Beacon Pharmaceuticals had annual revenue of 16.43B BDT with 30.96% growth. Beacon Pharmaceuticals had revenue of 4.41B in the quarter ending June 30, 2026, with 24.27% growth. That makes Beacon Pharmaceuticals the 20,724th largest company in the world by revenue and 45th in Bangladesh.

• Revenue: 16.43B
• Revenue Growth: +30.96%
• P/S Ratio: 1.31
• Revenue / Employee: 3.44M
• Employees: 4,771
• Market Cap: 21.44B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Bangladesh 12.35B 98.4%
• Export 195.53M 1.6%

Fiscal year ended Jun 30, 2025 See the full Beacon Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	16.43B	3.88B	30.96%
Jun 30, 2025	12.54B	1.84B	17.20%
Jun 30, 2024	10.70B	2.19B	25.76%
Jun 30, 2023	8.51B	487.21M	6.07%
Jun 30, 2022	8.02B	901.58M	12.66%

Data Source: S&P Global Market Intelligence Last updated: Oct 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error